Valink Therapeutics
PrivateLast Round
Seed
Oct 20, 2025
Est. Valuation
$1.79M
Total Funding Raised
$19.85M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Valink Therapeutics is a biotechnology company that develops next-generation, antibody-based therapeutics, specifically bispecific antibody-drug conjugates (bsADCs), to treat solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Valink Therapeutics Comparables
Compare Valink Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Archon Biosciences | 81% | |
| Arpelos Biosciences | 80% | |
| Fortitude Biomedicines | 76% | |
Valink Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 20, 2025 | ||||
| Seed | Nov 2, 2023 | ||||
| Accelerator | Mar 24, 2021 | ||||
| Accelerator | Jan 1, 2021 |
Key People
Founding team and executive leadership
Valink Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Saras Capital | Seed |
| Magnet Ventures | Seed |
| Metaplanet Holdings | Seed |
| Oxford Science Enterprises | Seed |
| Acequia Capital | Seed |
| Hoxton Ventures | Seed |
| Oxonian Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 17, 2025
Partnered with Nona Biosciences for integrated drug discovery solutions.
- Oct 20, 2025
$12M raised in early funding.
Valink Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Valink Therapeutics's valuation, stock price, and market status.